Award recognition emerges: Social media commentary highlighted Concentrix's recent win of the NiCE International CX Excellence Award alongside Currys for advancements in customer engagement strategies. Observers noted the accolade as a potential positive signal amid broader sector movements.
Trader interest noted: Discussions included mentions of CNXC in contexts of peer stock movements and dedicated trading communities. Some participants pointed to the company's inclusion in lists alongside other service providers following industry news.
Overall tone observed: Sentiment remains neutral with pockets of optimism tied to operational highlights. Analysts on social media avoided direct valuation calls while focusing on event-driven updates.
Note: This discussion summary was generated from an AI condensation of post data.
Concentrix Insider Trading Activity
Concentrix insiders have traded $CNXC stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CNXC stock by insiders over the last 6 months:
- BRUXELLES LAMBERT GROUPE sold 6,000,000 shares for an estimated $133,500,000
- ANDRE S VALENTINE (Chief Financial Officer) purchased 2,500 shares for an estimated $69,869
- CHRISTOPHER A CALDWELL (President and CEO) has made 2 purchases buying 2,000 shares for an estimated $48,219 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Concentrix Revenue
Concentrix had revenues of $2.5B in Q2 2026. This is an increase of 1.87% from the same period in the prior year.
You can track CNXC financials on Quiver Quantitative's CNXC stock page.
You can access data on CNXC stock through the Quiver Quantitative API.
Concentrix Hedge Fund Activity
We have seen 137 institutional investors add shares of Concentrix stock to their portfolio, and 181 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 1,919,052 shares (+520.3%) to their portfolio in Q1 2026, for an estimated $52,505,262
- AQR CAPITAL MANAGEMENT LLC added 1,881,581 shares (+63.8%) to their portfolio in Q1 2026, for an estimated $51,480,056
- KOPERNIK GLOBAL INVESTORS, LLC added 1,627,306 shares (+inf%) to their portfolio in Q1 2026, for an estimated $44,523,092
- FMR LLC added 1,414,243 shares (+50.3%) to their portfolio in Q1 2026, for an estimated $38,693,688
- CITADEL ADVISORS LLC added 1,124,167 shares (+1093.4%) to their portfolio in Q1 2026, for an estimated $30,757,209
- INVENOMIC CAPITAL MANAGEMENT LP removed 874,241 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $23,919,233
- QUANTINNO CAPITAL MANAGEMENT LP added 679,749 shares (+171.4%) to their portfolio in Q1 2026, for an estimated $18,597,932
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Concentrix Analyst Ratings
Wall Street analysts have issued reports on $CNXC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 06/30/2026
To track analyst ratings and price targets for Concentrix, check out Quiver Quantitative's $CNXC forecast page.
Concentrix Price Targets
Multiple analysts have issued price targets for $CNXC recently. We have seen 4 analysts offer price targets for $CNXC in the last 6 months, with a median target of $30.0.
Here are some recent targets:
- David Koning from Baird set a target price of $30.0 on 06/30/2026
- Luke Morison from Canaccord Genuity set a target price of $45.0 on 06/30/2026
- Vincent Colicchio from Barrington Research set a target price of $30.0 on 06/30/2026
- Ruplu Bhattacharya from B of A Securities set a target price of $26.0 on 06/30/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
